EDB works with Johnson & Johnson to innovate SG’s life sciences
The collaboration backs early-stage firms and fast track innovative medicines.
Johnson & Johnson Innovation and the Singapore Economic Development Board (EDB) will collaborate to support life sciences innovation in the city-state.
“This collaboration is the first of its kind and will leverage Johnson & Johnson Innovation – JLABS’ services and innovation resources aimed at boosting the region’s innovation output,” read the statement.
JLABS will support early-stage firms with a location in Singapore to speed up their discoveries into innovative medicines, medical technologies, and healthcare solutions.
JLABS will also collaborate with local incubators and other strategic partners in the ecosystem on venture and talent development offerings to develop employment and commercialisation opportunities for early-stage companies.
The partnership complies with J&J’s commitment to speed up science and technology development in the Asia Pacific region, with the goal of addressing critical healthcare needs.